Abstract

Background: Diabetes mellitus is the frequent cause of sexual dysfunction in males. Various studies have reported 25 – 32 % of men with Diabetes mellites complaining of sexual dysfunction. 

Material and Methods: This was a prospective observational study, conducted among 100 men (aged 35-60 years) with type 2 diabetes  /No Diabetes (50 cases each) and with complaints of sexual dysfunction, from June 2015 to and February May 2016.

Results: Mean age of diabetics was 44.5 ±7.9 years and non diabetics was 42.54 ± 5.63 years. 56% of Diabetics and 20 % non diabetics had lower levels of total testosterone.68% of Diabetics and 26 % non diabetics had lower levels of free testosterone. Mean serum free testosterone in diabetics was 3.2 ± 0.78 and in non diabetics was 6.2 ± 3. Mean serum FSH level in diabetics was 4.3 ± 1.2 and in non diabetics was 9 ± 1.8. Mean serum LH level in diabetics was 6.4 ± 2.1  and in non diabetics was 12 ± 2.8. Mean Prolactin levels in Diabetics and non Diabetics was 10.5 ± 2.6 and 15 ± 2.5. Mean SHBG levels in Diabetics and non – diabetics was 8.6 ± 1.8 and 16 ± 3.2. Prevalence of Hypogonadism was 22% in Diabetics and 10% in Non diabetics.

Conclusion: Hypogonadism is more prevalent in patients with Type 2 Diabetes mellites than non-diabetics. It is associated with low levels of free testosterone.

Keywords: Type 2 Diabetes Mellites, Sexual Dysfunction, Low serum total testosterone, Hypogonadism

1.      Tripathy D, Dhindsa S, Garg R, Khaishagi A, Syed T, Dandona P. Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: A common defect? Metab Syndr Relat Disord. 2003;1:75–80.

2.      Morales A. Androgens are fundamental in the maintenance of male sexual health. CurrUrol Rep. 2011;12(6):453–460

3.      Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care. 2005; 28:164–76.

4.      Cai X, Tian Y, Wu T, Cao CX, Li H, Wang KJ. Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Asian J Androl.  2014;16(1):146–152.

5.      Shaheen DA, Shaheen DA, Habib AA, Ali AME. The effect of serum free testosterone level on glycemic control and atherosclerosis in type 2 diabetic men. AdvBiochem. 2014;2(2):34–39.

6.      Wilkinson CP, Ferris FL, 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology.  2003;110:1677–82

7.      Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P. Testosterone concentration in young patients with diabetes. Diabetes Care. 2008;31:2013–7. 

8.      Caronia LM, Dwyer AA, Hayden D, Amatti F, Pitteloud N, Hayes FJ. Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism.  Clin Endocrinol. 2013;78:291–296. 

9.      Hall SA, Esche GR, Araujo AB, Travison TG, Clark RV, Williams RE, et al. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. J Clin Endocrinol Metab. 2008;93:3870–7.

10.  Wong SY, Chan DC, Hong A, Woo J. Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong. Metabolism. 2006;55:1488–94.

11.  RamkishanJat, Mandavi Agarwal .Comparison Of Serum   Testosterone, Luteinizing Hormone And Follicle Stimulating Hormone Levels In Diabetics And NonDiabetics Men –A Case –Control Study. Journal of Dental and Medical Sciences .2012: 65-71

12.  Dhindsa S; Michael G Miller; Cecilia L McWhirter; Donald E Mager; Husam... Testosterone Concentrations in Diabetic and Nondiabetic Obese Men;Diabetes Care;  2010; 33: 1186

13.  Ganesh HK, VijayaSarathi HA, George J, Shivane VK, Bandgar T, Menon PS, et al. Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group.  Endocr Pract.  2009;15:513–20.

14.  Janjgava S, Zerekidze T, Uchava L, Giorgadze E, Asatiani K. Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency. Eur J Med Res. 2014;19(1):56.